Form 8-K - Current report:
SEC Accession No. 0001104659-24-007712
Filing Date
2024-01-29
Accepted
2024-01-29 16:01:10
Documents
16
Period of Report
2024-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244111d1_8k.htm   iXBRL 8-K 23259
2 EXHIBIT 99.1 tm244111d1_ex99-1.htm EX-99.1 25611
3 GRAPHIC tm244111d1_ex99-1img001.jpg GRAPHIC 4105
  Complete submission text file 0001104659-24-007712.txt   235505

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vstm-20240129.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20240129_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20240129_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm244111d1_8k_htm.xml XML 3606
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 24573566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)